Alignment Healthcare, Inc. (ALHC) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001832466 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $1.34B | $36.6M | $0.17 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $1.24B | $11.4M | $0.05 | Filing |
| Dec 31, 2025 | Feb 26, 2026 | $1.01B | $-11.0M | $-0.04 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $993.7M | $3.7M | $0.02 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $1.02B | $15.7M | $0.07 | Filing |
| Mar 31, 2025 | May 1, 2025 | $926.9M | $-9.1M | $-0.05 | Filing |
| Dec 31, 2024 | Feb 27, 2025 | $701.2M | $-31.1M | $-0.15 | Filing |
| Sep 30, 2024 | Oct 29, 2024 | $692.4M | $-26.4M | $-0.14 | Filing |
What would Alignment Healthcare, Inc. have to report for its valuation to change?
At $8.28, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 28.8% a year, to $0.71. On that path the next quarter needs diluted EPS near $0.03, against $0.02 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 28.8% | 28.8% |
| EPS needed in final year | $0.71 | $0.71 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. ALHC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.